Inbunden, Engelska, 2026

Ethical Standards and Regulatory Compliance in Preclinical Animal Studies

A Global Perspective

Av Prashant Tiwari, Sunil Kumar Kadiri, Merugumolu Vijay Kumar

Del i serien CABI Publishing

1515 kr

Kommande

Beskrivning

Animal studies play a vital role in the development of new medications, medical devices, and therapeutic methods. It is essential, however, that these studies adhere to ethical standards and international regulations to maintain scientific integrity and public confidence in biomedical research. Designed to provide researchers, regulatory professionals, ethics committee members, and institutional leaders with a thorough understanding of ethical standards and the challenges of compliance in preclinical animal research, this book covers regulatory frameworks from around the world, including the USA, European Union, Japan and Australia. Selected for their global impact, these regions represent diverse approaches to compliance while shaping standards internationally. This book also: - highlights the 3Rs principle of replacement, reduction and refinement within animal studies - includes case studies from prominent research institutions worldwide - provides practical advice on navigating international regulations Also exploring recent technological advancements that promote ethical research, including in vitro alternatives and computational models, this book encourages responsible and compliant research practices that promote scientific advancement while ensuring the humane treatment of laboratory animals.

Produktinformation

Utgivningsdatum: 2026-07-31
Mått: 172 x 244 x 9 mm
Vikt: 317 g
Format: Inbunden
Språk: Engelska
Serie: CABI Publishing
Antal sidor: 160
Förlag: CABI Publishing
ISBN: 9781836992110

Utforska kategorier

Mer om författaren

Prashant Tiwari (Author) Dr. Prashant Tiwari, Ph.D., is an Associate Professor in the Department of Pharmacology at the College of Pharmaceutical Sciences, Dayananda Sagar University, Bengaluru, India. He holds a Ph.D. from Siksha O Anusandhan University, Bhubaneswar, and was a fellow of the Indian Council of Medical Research (ICMR), New Delhi. With over 13 years of experience in teaching and research, Dr. Tiwari's expertise includes drug screening, method validation for brain-targeted drug delivery, drug-induced dyskinesia revalidation, and the neuroprotective effects of benzimidazole derivatives. His research has explored the dopaminergic pathway, prolactin inhibition, and neuroprotection, with notable studies on Nanoemulsions containing Lepidium sativum oil for Parkinson's disease and Muntingia Calabura leaf extract for Alzheimer's disease. For his outstanding work, Dr. Tiwari received the Dr. P. D. Patil National Award for Best Thesis in Pharmaceutical Sciences (2022). In addition to his research, Dr. Tiwari has authored 5 books, edited 5 books, and co-authored 6 book chapters. He has filed 7 patents, 2 of which have been granted. He organized a national e-seminar on targeted drug delivery against neurodegenerative diseases, sponsored by the Department of Biotechnology (DBT), Government of India. Dr. Tiwari has been honored with various awards, including the ICMR Senior Research Fellowship, Young Scientist Award, and Best Teacher Award. He supervises 5 Ph.D. students and has guided 9 M. Pharm students. He is also an active member of professional bodies and serves as a peer reviewer for international journals. His research interests span neurodegenerative disorders, drug interactions, pharmacokinetics/pharmacodynamics, and metabolic disorders.Sunil Kumar Kadiri (Author) Dr Sunil Kumar Kadiri is a Professor at the College of Pharmaceutical Sciences, Dayananda Sagar University, Bengaluru, Karnataka, with 16 years of teaching experience. His research interests encompass neuropharmacology, metabolic disorders, organ-protective activities, and drug interactions. He holds a Ph.D. in Pharmaceutical Sciences from JNTU Hyderabad and has authored 65 research and review articles. In addition to publishing 5 books and 4 book chapters, he holds 6 patents. An active member of APTI, his recent research includes drug interaction studies involving Alprazolam and Pomegranate, Carbamazepine and Losartan, Naproxen and St. John's Wort, as well as investigations into the antiparkinsonian effects of Zinda Tilismath.Merugumolu Vijay Kumar (Author) Dr Merugumolu Vijay Kumar is a pharmacologist currently working as Associate Professor at the College of Pharmacy, Dayanand Sagar University, Bengaluru, Karnataka. With 12 years of experience, he is an active collaborator interested in conducting animal experiments in new models for pharmacological screening, developing labs for animal experimentation and animal housing facilities, and interdisciplinary research. He has published more than 35 articles in national and international journals and presented numerous papers at international and national conferences. Vijay was awarded the Young Scientist award at the Golden Global Health and Education International Conference held in 2019 in Dubai, and named one of the 100 Most Impactful Healthcare Leaders in the global listing unveiled in the same year in Mumbai.

Betyg & recensioner

0 recensioner

Inga recensioner tillgängliga.